Prospectively Defined Clusters of Coronavirus Disease 2019 Sequelae

• by Shritha Velaga, Justin Stebbing

• June 25, 2024

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

• by Kathryn Wighton

• May 12, 2026

• 2 min

Assessing PEPFAR’s Economic and Educational Spillover Effects: An Update

• by William Crown, Jennifer Kates, Deborah Stenoien, Allyala Nandakumar

• May 20, 2026

Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra

• by Shirkhan Amikishiyev, Rabia Deniz, Mehmet Guven Gunver, Sarvan Aghamuradov, Nevzat Koca, Burak Ince, Murat Bektas, Aysenur Yilmaz, Yagmur Canturk, Gorkem Durak, Murat Kose, Mustafa Erelel, Arif Atahan Çağatay, Serap Simsek Yavuz, Sevgi Kalayoglu Besisik, Figen Esen, Ahmet Gül

• May 22, 2026